Pulmuone Corporate (KRX:017810)
9,710.00
+650.00 (7.17%)
Jun 9, 2026, 11:30 AM KST
Pulmuone Corporate Revenue
Pulmuone Corporate had revenue of 850.35B KRW in the quarter ending March 31, 2026, with 7.17% growth. This brings the company's revenue in the last twelve months to 3.44T, up 6.15% year-over-year. In the year 2025, Pulmuone Corporate had annual revenue of 3.38T with 5.18% growth.
Revenue (ttm)
3.44T
Revenue Growth
+6.15%
P/S Ratio
0.10
Revenue / Employee
6.77B
Employees
508
Market Cap
334.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.38T | 166.49B | 5.18% |
| Dec 31, 2024 | 3.21T | 220.23B | 7.36% |
| Dec 31, 2023 | 2.99T | 155.16B | 5.47% |
| Dec 31, 2022 | 2.84T | 319.41B | 12.68% |
| Dec 31, 2021 | 2.52T | 207.70B | 8.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daesang Holdings | 5.65T |
| Sajodaerim | 3.53T |
| EASY HOLDINGS | 3.40T |
| Samlip | 3.37T |
| Samyang | 2.55T |
| Maeil Dairies | 1.85T |
| Kwang Dong Pharmaceutical | 1.69T |
| Binggrae | 1.49T |